“How an ANDA Gets Approved” 1 Topics Covered • Recent events affecting approval • Overview of the disciplines involved in the approval process • Areas for industry assistance 2 Early Challenges • Implementation of the Informatics Platform (IT) - New archival system used to track and process applications - Went live October 1, 2014 • Reorganization - Creation of the Office of Pharmaceutical Quality - Separating several review disciplines from OGD • Increase in new staff - Addition of many new reviewers - Experienced reviewers involved in training 3 Recent Improvements • Informatics Platform has been tailored to meet our needs • OPQ settled into the reorganization, new processes in place • New hires becoming more productive • Experienced reviewers returning to spending more time reviewing applications 4 FY15 Trends (ANDA Originals) – Actions Taken by Month (Totals) Complete Response (CR), Approval (AP), & Tentative Approval (TA) CR AP TA Grand Oct 14 Nov 14 Dec 14 Jan 15 Feb 15 Mar 15 Apr 15 May 15 Jun 15 Jul 15 Aug 15 Sept 15 Total AP 43 28 29 26 27 19 49 46 58 47 58 61 491 CR 44 76 96 104 109 93 115 97 97 129 95 100 1155 TA 10 7 5 5 14 6 20 13 10 12 6 14 122 Emphasis to Reduce Number of Review Cycles • Goal to reduce the time for an ANDA to be approved • Need improved applications from the applicant • Increased number of Information Request (IR)/Easily Correctable Deficiencies (ECD) communications 6 FY15 Trends (ANDA Originals) – Actions Taken by Month (Totals) ECD/IR ECD/IR (Data as of 9/21/2015) + + 54 493 2,115 2,662 FDA Pending Filed –No = Filing Review At Least One Review Snapshot with Review Comm. Communication Issued FDA T C e o 3 n m t 0 a Monthly ple 83 6 tiv Average te Re ents Info e Ap + s m Req. p p r (May - August) onse mend 54 ovals 9 A 8 1 9 0 872 276 1,148 Industry Pending + Tentative = Industry Response to Approval Snapshot with the Complete with Industry Response Industry Current ANDA Workload of 3,810 Original Applications Refuse to Total Pre-Y3 1,293 398 Receive + + + = Application Cohort Approva 78 Withdrawal 3,810 5,707 Resubmitted in Y3 ls s (As of 10/1/2012) 128 No (from Cohort) Resubmission FILING STAGE 9 Division of Filing Review 10
Description: